- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/60 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 317/60
Total number of patents in this class: 152
10-year publication summary
|
9
|
9
|
9
|
10
|
7
|
6
|
6
|
9
|
12
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1600 |
7 |
| Tasly Pharmaceutical Group Co., Ltd. | 119 |
6 |
| BASF SE | 20940 |
5 |
| Novartis AG | 10744 |
4 |
| Texas Heart Institute | 105 |
4 |
| Toyama Chemical Co., Ltd. | 102 |
4 |
| Enveric Biosciences Canada Inc. | 62 |
4 |
| Aurimmed Pharma, Inc. | 7 |
3 |
| Council of Scientific & Industrial Research | 1427 |
3 |
| Italfarmaco SpA | 148 |
3 |
| New York University | 1751 |
3 |
| Symrise AG | 1727 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 875 |
3 |
| H. Lundbeck A/S | 1250 |
3 |
| Awakn LS Europe Holdings Limited | 14 |
3 |
| F. Hoffmann-La Roche AG | 7947 |
2 |
| Merck Patent GmbH | 5815 |
2 |
| Academia Sinica | 940 |
2 |
| Augusta University Research Institute, Inc. | 145 |
2 |
| CHDI Foundation, Inc. | 106 |
2 |
| Other owners | 84 |